The Immuno-Oncology Podcast

Bristol Myers Squibb

The Bristol Myers Squibb Immuno-Oncology Podcast is dedicated to keeping listeners updated on current findings in the immuno-oncology treatment landscape.

About PodLP

PodLP is the leading podcast app for feature phones. With 10M+ installs in nearly every country, PodLP is available for KaiOS on the KaiStore and JioStore, as well as Cloud Phone and Android. If you're interested in promoting "The Immuno-Oncology Podcast" on PodLP, contact sales@podlp.com.

Screenshots are mockup renders of PodLP for KaiOS. Actual design may vary based on platform, operating system, and app version.

The Immuno-Oncology Podcast

Episodes (1)

Apr 19, 2023 Tx Option in 1L NSCLC for PD-L1 <1% Patients
Apr 19, 2023 Dr. Jason Porter on Neoadjuvant Treatment for Resectable NSCLC
Apr 19, 2023 Dr. Shilpa Gupta, MD, on an Adjuvant I-O Therapy in UC

The Immuno-Oncology Podcast

Apr 19, 2023
31¾ minutes
27 MB

Do PD-L1 expression levels influence non-small cell lung cancer patients’ outcomes? Special guest Jason Porter, MD., discusses how PD-L1 levels affected treatment outcomes in a clinical study for recurrent or metastatic non-small cell lung cancer. Dr. Porter is a medical oncologist and hematologist at the West Cancer Center and Research Institute where he is the Director of the Lung Cancer disease research group. Hear for yourself if it is possible to treat patients with low levels of PD-L1 with I-O therapy. Learn more about a treatment option for patients with recurrent or metastatic non-small cell lung cancer wi...

The Immuno-Oncology Podcast

Tx Option in 1L NSCLC for PD-L1 <1% Patients

Bristol Myers Squibb

00:00 -29:55